Notice of Failure to Satisfy a Continued Listing Rule
/PRNewswire/ -- On September 15, 2022, Lixiang Education Holding Co., Ltd (the "Company") received a written notice (the "Notice") from the Listing...
Source: prnewswire.com
Page 47 - Lishui News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lishui. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lishui Today - Breaking & Trending Today
Farmmi Announces Latest Multi-Product Order; Exporting to Israel as Part of Ongoing Broader Market Expansion
LISHUI, China, Sept. 20, 2022 /PRNewswire/ -- Farmmi, Inc. ('Farmmi' or the 'Company') (NASDAQ: FAMI), an agricultural products supplier in China,...
Source: businessinsider.com
Taking heart in tradition
When Shi Donglai was younger, he took for granted the importance of traditional Chinese festivals and family ties. But today they resonate with the 29-year-old more strongly than ever.
Source: chinadaily.com.cn
I-Mab Announces Approval from China CDE to Initiate Phase 3 Registrational Study of Lemzoparlimab in Combination with Azacitidine in Higher-Risk Myelodysplastic Syndrome
GAITHERSBURG, Md. and SHANGHAI, Sept, 13, 2022 /PRNewswire/ -- I-Mab (the 'Company') (Nasdaq: IMAB), a clinical-stage biopharmaceutical company co...
Source: businessinsider.com
I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022
Lemzoparlimab combined with AZA showed encouraging clinical response in higher-risk MDS patientsFor patients received initial dose over 3 months, the ORR is 80.6% and for patients received initial... | September 10, 2022
Source: marketscreener.com